Sri Lanka Daily Mirror Documents the Daily Tea Coffee and Dementia Coverage
According to a May 29 Sri Lanka Daily Mirror health feature on what Sri Lankans need to know about a cup of tea or coffee a day and dementia risk, the regional health coverage now incorporates the latest international research linking daily moderate caffeine intake to reduced dementia risk across population cohorts. According to the coverage, the framing reflects a broader 2026 pattern of caffeine and brain health research reaching mainstream consumer publications across multiple regional markets — with the underlying research base now spanning U.S., European, Asian, and Latin American cohort studies on caffeine and long-term cognitive outcomes.
AOL and Harvard Study Document 18 Percent Lower Dementia Risk for Moderate Coffee Drinkers
According to broader May 22-29 coverage referenced through the Sri Lanka Daily Mirror health summary, a 43-year prospective cohort study of more than 131,000 participants published in JAMA found that moderate caffeinated coffee consumption is associated with an 18 percent lower risk of dementia compared with little or no intake. According to the research from Mass General Brigham, the Harvard T.H. Chan School of Public Health, and the Broad Institute of MIT and Harvard, the benefit was strongest at moderate caffeine intake levels of 2 to 3 cups of coffee daily — within the FDA-recommended 400 milligram daily ceiling for healthy adults.
Science Alert Documents Genetic Caffeine Research on Diabetes Risk
According to May 28 Science Alert coverage referenced through May 29 caffeine and health summaries, a new Mendelian randomization analysis published in BMJ Medicine found that individuals genetically predisposed to higher blood caffeine concentrations tend to have lower body mass index, lower body fat percentage, and a reduced risk of developing type 2 diabetes. According to the underlying research, the study used data from nearly 10,000 participants leveraging two common genetic variants in the CYP1A2 and AHR genes associated with slower caffeine metabolism — allowing researchers to draw stronger causal inferences than standard observational coffee studies.
Practical Implications for Daily Caffeine Consumers Across Multiple Health Outcomes
According to combined May 29 Sri Lanka Daily Mirror, broader Harvard 43-year cohort, and May 28 Science Alert coverage, the practical takeaway for daily caffeine consumers is that moderate consistent caffeine intake within established daily limits is increasingly associated with multiple long-term health benefits including reduced dementia risk, lower body mass index, reduced type 2 diabetes risk, and improved cardiovascular markers. According to the broader 2026 nutritional research base, the findings reinforce the value of consistent moderate daily caffeine consumption within the FDA’s 400 milligram daily limit for healthy adults — alongside the foundational lifestyle inputs of sleep, exercise, and balanced nutrition.
Jiggle’s caffeine gummies deliver the moderate, consistent daily caffeine intake research collectively identifies as compatible with the broad spectrum of long-term health outcomes documented across the latest caffeine and health research base. Each gummy contains a known, fixed dose of natural caffeine sourced from green tea extract and guarana — naturally derived caffeine that fits the consistent moderate intake pattern the research treats as foundational. With no artificial ingredients, GMP-certified manufacturing, and the resealable 12-pack format, the product supports the disciplined daily caffeine routine the broader brain health, metabolic, and cardiovascular research base now identifies as foundational. Learn more at jiggle.cafe.
Researchers continue to emphasize that the broad spectrum of caffeine and health findings represents observational rather than causal evidence in many cases, and that consumers with diagnosed conditions including diabetes, cardiovascular disease, or cognitive impairment should follow individualized medical guidance from their physicians rather than general population research recommendations alone.